SIDRX | VIHAX | SIDRX / VIHAX | |
Total Expense Ratio | 0.76 | 0.17 | 447% |
Annual Report Gross Expense Ratio | 0.76 | 0.17 | 447% |
Fund Existence | 10 years | 9 years | - |
Gain YTD | 21.508 | 17.828 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 3000 | 166,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.31B | 11B | 21% |
Annual Yield % from dividends | 2.59 | 4.14 | 63% |
Returns for 1 year | 19.02 | 13.72 | 139% |
Returns for 3 years | 33.74 | 25.45 | 133% |
Returns for 5 years | 69.30 | 54.53 | 127% |
Returns for 10 years | 70.12 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MNHRX | 25.79 | N/A | N/A |
Manning & Napier Pro-Blend Max Term R | |||
FBTTX | 23.77 | N/A | N/A |
Fidelity Advisor Biotechnology M | |||
FEYTX | 27.31 | N/A | N/A |
Fidelity Advisor Asset Manager 85% M | |||
EEMGX | 8.78 | N/A | N/A |
MFS Emerging Markets Equity Research R4 | |||
GQFIX | 12.16 | N/A | N/A |
GQG Partners Global Quality Value Fd Ins |